Samsung Bioepis Co., Ltd. announced the relaunch of Byooviz (ranibizumab-nuna) in the United States (US), in partnership with Harrow. Harrow became responsible for commercialization of Byooviz ...

US FDA grants breakthrough therapy designation for INTENT Biologics’ PEP Biologic to treat diabetic foot ulcers: Rochester, Minnesota Friday, July 3, 2026, 09:00 Hrs [IST] INTEN ...

Draft NPC Bill, 2026 to strengthen and modernize pharmacy education regulation: FOPE: Nandita Vijayasimha, Bengaluru Friday, July 3, 2026, 08:00 Hrs [IST] The Federation of Pharma ...

SEC asks Abbvie to conduct Phase III study on subcutaneous drug for Parkinson's disease: Our Bureau, New Delhi Friday, July 3, 2026, 08:00 Hrs [IST] A Subject Expert Committee (SE ...

Associations demand representations for working pharmacists in proposed NPC: Peethaambaran Kunnathoor, Chennai Friday, July 3, 2026, 08:00 Hrs [IST] In a unified push to ensure gr ...

Draft NPC Bill proposes NET for registration of pharmacists, separate provisions for ISM: Gireesh Babu, New Delhi Friday, July 3, 2026, 08:00 Hrs [IST] The revised draft National ...

US FDA approves Orca Bio’s Tregzi for allogeneic transplant in adults with haematological malignancies: Menlo Park, California Thursday, July 2, 2026, 17:00 Hrs [IST] Orca Bio, ...

La Chandra Pharmalab's Banaskantha Hormone API facility receives USFDA clearance: Our Bureau, Mumbai Thursday, July 2, 2026, 14:45 Hrs [IST] La Chandra Pharmalab has received an E ...

FICCI opens global growth gateway for Indian pharma with exclusive SAIF Zone B2B meetings in Hyderabad: Shardul Nautiyal, Mumbai Thursday, July 2, 2026, 13:15 Hrs [IST] In a signi ...

NIH's All of Us Research Programme is now the largest integrated genomics and health database in the world: Maryland Thursday, July 2, 2026, 16:00 Hrs [IST] The National Institute ...

Health Canada approves Apotex Health’s Sevmia, a generic semaglutide for chronic weight management: Toronto, Ontario Thursday, July 2, 2026, 15:00 Hrs [IST] Apotex Health Corp.

Hengrui Pharma’s cyclosporine ophthalmic solution ‘Heng Yi’ receives China NMPA approval for treatment of dry eye disease: Shanghai Thursday, July 2, 2026, 18:00 Hrs [IST] H ...